Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Imiquimod for Oral Dysplasia
NCT07210775Phase 2Recruiting
- Sponsor
- University of Southern California
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Irreversible Covalent Inhibitors, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of imiquimod in Oral epithelial dysplasia (OED), sponsored by University of Southern California. Started Oct 2025; status: recruiting.
02
Drugs
imiquimod
03
Conditions
Oral epithelial dysplasia (OED)
Beyond the preview
Go deeper on NCT07210775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07210775.